These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34740359)

  • 121. A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries.
    Bhutta ZA; Salam RA; Gomber A; Lewis-Watts L; Narang T; Mbanya JC; Alleyne G
    Lancet; 2021 Nov; 398(10313):1837-1850. PubMed ID: 34774146
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Interpreting Absolute and Relative Risk Reduction in the Context of Recent Cardiovascular Outcome Trials in Patients with Type 2 Diabetes.
    Berg DD; Kolkailah AA; Sarraju A; Kerchberger AM; Eljalby M; McGuire DK
    Curr Diab Rep; 2021 Nov; 21(11):45. PubMed ID: 34741199
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Diagnosis and treatment of primary aldosteronism.
    Reincke M; Bancos I; Mulatero P; Scholl UI; Stowasser M; Williams TA
    Lancet Diabetes Endocrinol; 2021 Dec; 9(12):876-892. PubMed ID: 34798068
    [TBL] [Abstract][Full Text] [Related]  

  • 124. When and how to deintensify type 2 diabetes care.
    Aubert CE; Lega IC; Bourron O; Train AJ; Kullgren JT
    BMJ; 2021 Nov; 375():e066061. PubMed ID: 34740903
    [No Abstract]   [Full Text] [Related]  

  • 125. Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.
    Zhang N; Wang Y; Tse G; Korantzopoulos P; Letsas KP; Zhang Q; Li G; Lip GYH; Liu T
    Eur J Prev Cardiol; 2022 Feb; 28(17):1961-1973. PubMed ID: 34792124
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors.
    Fadini GP; Del Prato S; Avogaro A; Solini A
    Diabetes Obes Metab; 2022 Feb; 24(2):177-186. PubMed ID: 34747123
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Heart failure and diabetes: Clinical significance and epidemiology of this two-way association.
    Jerkins T; McGill JB; Bell DSH
    Diabetes Obes Metab; 2023 Jul; 25 Suppl 3():3-14. PubMed ID: 36949650
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context.
    Leulseged TW; Hassen IS; Maru EH; Zewsde WC; Chamiso NW; Bayisa AB; Abebe DS; Ayele BT; Yegle KT; Edo MG; Gurara EK; Damete DD; Tolera YA
    PLoS One; 2021; 16(11):e0259454. PubMed ID: 34752481
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Comorbidity and prognostic factors on admission in a COVID-19 cohort of a general hospital.
    Martos Pérez F; Luque Del Pino J; Jiménez García N; Mora Ruiz E; Asencio Méndez C; García Jiménez JM; Navarro Romero F; Núñez Rodríguez MV
    Rev Clin Esp (Barc); 2021 Nov; 221(9):529-535. PubMed ID: 34752264
    [TBL] [Abstract][Full Text] [Related]  

  • 130. COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent.
    Bhargava D; Ahirwal R; Dubey S; Gurjar P; Pandey A; Beena S; Koneru G
    Head Neck Pathol; 2022 Sep; 16(3):645-650. PubMed ID: 34751896
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes.
    Salvatore T; Galiero R; Caturano A; Vetrano E; Rinaldi L; Coviello F; Di Martino A; Albanese G; Colantuoni S; Medicamento G; Marfella R; Sardu C; Sasso FC
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204677
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Association Between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients With Type 2 Diabetes.
    Au PCM; Tan KCB; Cheung BMY; Wong ICK; Wong Y; Cheung CL
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1719-e1726. PubMed ID: 34748021
    [TBL] [Abstract][Full Text] [Related]  

  • 133. [“Dum spiro spero”: clinicopathologic characteristics of SARS-CoV-2 infection].
    Zombori T; Kuthi L; Hortobágyi T; Csörgő E; Árgyelán J; Kocsis L; Sejben I; Kaizer L; Radics B; Sejben A; Pancsa T; Nyári GR; Baráth B; Cserni G; Iványi B; Tiszlavicz L
    Orv Hetil; 2021 Nov; 162(45):1791-1802. PubMed ID: 34747358
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Severe Hypoglycemia and Incident Heart Failure Among Adults With Type 2 Diabetes.
    Echouffo-Tcheugui JB; Kaze AD; Fonarow GC; Dagogo-Jack S
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e955-e962. PubMed ID: 34741460
    [TBL] [Abstract][Full Text] [Related]  

  • 135. The effect of underlying diabetes disease on clinical outcome and survival in patients with Covid-19: a propensity score matching study.
    Ghadamgahi F; Tapak L; Bashirian S; Amiri R; Roshanaei G
    J Diabetes Metab Disord; 2021 Dec; 20(2):1675-1683. PubMed ID: 34746038
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Pulmonary mucormycosis-a case series.
    Benjamin SR; Narayanan D; Chandy ST; Gnanamuthu BR; Michael JS; Kodiatte TA
    Indian J Thorac Cardiovasc Surg; 2022 Mar; 38(2):177-182. PubMed ID: 34744334
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Glimepiride Use is Associated with Reduced Cardiovascular Mortality in Patients with Type 2 Diabetes and Chronic Heart Failure: A Prospective Cohort Study.
    He W; Yuan G; Han Y; Yan Y; Li G; Zhao C; Shen J; Jiang X; Chen C; Ni L; Wang DW
    Eur J Prev Cardiol; 2022 Dec; ():. PubMed ID: 36573717
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Diabetic microvascular complications predicts non-heart failure with reduced ejection fraction in type 2 diabetes.
    Tochiya M; Makino H; Tamanaha T; Omura-Ohata Y; Matsubara M; Koezuka R; Noguchi M; Tomita T; Asaumi Y; Miyamoto Y; Yasuda S; Hosoda K
    ESC Heart Fail; 2023 Apr; 10(2):1158-1169. PubMed ID: 36630988
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Telemedicine and COVID-19 pandemic: The perfect storm to mark a change in diabetes care. Results from a world-wide cross-sectional web-based survey.
    Giani E; Dovc K; Dos Santos TJ; Chobot A; Braune K; Cardona-Hernandez R; De Beaufort C; Scaramuzza AE;
    Pediatr Diabetes; 2021 Dec; 22(8):1115-1119. PubMed ID: 34741569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.